Total Payments
$978.18
2024 Payments
$556.49
Companies
12
Transactions
51
Medicare Patients
1,071
Medicare Billing
$88,514
Payment Breakdown by Category
Food & Beverage$978.18 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $978.18 | 51 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $312.52 | 19 | $0 (2024) |
| Janssen Biotech, Inc. | $285.34 | 12 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $152.79 | 8 | $0 (2024) |
| Merck Sharp & Dohme LLC | $48.27 | 2 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $42.30 | 2 | $0 (2024) |
| PFIZER INC. | $30.95 | 2 | $0 (2024) |
| GENZYME CORPORATION | $21.28 | 1 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $19.50 | 1 | $0 (2024) |
| Ardelyx, Inc. | $18.31 | 1 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $17.09 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $556.49 | 28 | ABBVIE INC. ($228.21) |
| 2023 | $352.70 | 19 | Janssen Biotech, Inc. ($86.69) |
| 2022 | $16.11 | 1 | Ironwood Pharmaceuticals, Inc ($16.11) |
| 2021 | $52.88 | 3 | Ironwood Pharmaceuticals, Inc ($52.88) |
All Payment Transactions
51 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $111.70 | General |
| Category: Immunology | ||||||
| 12/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $0.31 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Immunology | ||||||
| 11/18/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/08/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Gastroenterology | ||||||
| 09/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Immunology | ||||||
| 09/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Immunology | ||||||
| 09/24/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: IMMUNOLOGY | ||||||
| 09/20/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/06/2024 | ABBVIE INC. | LINZESS (Drug), VIBERZI, CREON | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/24/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $9.52 | General |
| Category: Immunology | ||||||
| 07/09/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: Immunology | ||||||
| 06/25/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 06/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: IMMUNOLOGY | ||||||
| 05/14/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Immunology | ||||||
| 03/13/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $21.09 | General |
| Category: GI | ||||||
| 03/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/08/2024 | ABBVIE INC. | VIBERZI (Drug), LINZESS, CREON | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/31/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 310 | 588 | $138,550 | $30,160 |
| 2022 | 7 | 294 | 327 | $112,213 | $23,275 |
| 2021 | 5 | 254 | 301 | $58,034 | $21,875 |
| 2020 | 4 | 213 | 241 | $43,469 | $13,204 |
Total Patients
1,071
Total Services
1,457
Medicare Billing
$88,514
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 113 | 130 | $45,500 | $9,951 | 21.9% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 14 | 169 | $16,900 | $5,239 | 31.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 82 | 97 | $29,100 | $5,091 | 17.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 14 | 100 | $15,000 | $4,102 | 27.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $18,600 | $2,839 | 15.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 25 | 26 | $5,200 | $1,298 | 25.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 20 | $6,000 | $1,011 | 16.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 15 | 15 | $2,250 | $628.10 | 27.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 119 | 139 | $47,552 | $10,424 | 21.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 76 | 84 | $24,762 | $4,565 | 18.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 28 | 30 | $11,814 | $3,464 | 29.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 19 | 19 | $9,500 | $1,545 | 16.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $9,000 | $1,487 | 16.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 18 | 19 | $5,700 | $900.50 | 15.8% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 19 | 21 | $3,885 | $890.05 | 22.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 114 | 138 | $31,464 | $10,787 | 34.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 51 | 67 | $11,055 | $4,915 | 44.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 44 | 48 | $7,392 | $2,671 | 36.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 31 | 34 | $3,825 | $1,897 | 49.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 14 | 14 | $4,298 | $1,606 | 37.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 86 | 99 | $22,572 | $5,743 | 25.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 48 | 51 | $8,335 | $3,579 | 42.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 51 | 59 | $8,962 | $2,328 | 26.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 28 | 32 | $3,600 | $1,554 | 43.2% |
About Amanda Chase, NP
Amanda Chase, NP is a Family healthcare provider based in Asheville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/03/2015. The National Provider Identifier (NPI) number assigned to this provider is 1992197776.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amanda Chase, NP has received a total of $978.18 in payments from pharmaceutical and medical device companies, with $556.49 received in 2024. These payments were reported across 51 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($978.18).
As a Medicare-enrolled provider, Chase has provided services to 1,071 Medicare beneficiaries, totaling 1,457 services with total Medicare billing of $88,514. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Asheville, NC
- Active Since 03/03/2015
- Last Updated 11/03/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1992197776
Products in Payments
- TREMFYA (Drug) $160.41
- Linzess (Drug) $152.79
- RINVOQ (Biological) $125.56
- STELARA (Biological) $106.51
- SKYRIZI (Biological) $65.59
- CREON (Drug) $63.03
- DIFICID (Drug) $48.27
- ENTYVIO (Biological) $42.30
- LINZESS (Drug) $34.70
- XELJANZ (Drug) $30.95
- VIBERZI (Drug) $23.64
- DUPIXENT (Biological) $21.28
- XIFAXAN (Drug) $19.50
- REMICADE (Biological) $18.42
- IBSRELA (Drug) $18.31
- ZENPEP (Drug) $17.09
- OCALIVA (Drug) $15.45
- VOQUEZNA (Drug) $14.38
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Asheville
Mr. Frank Russo, Fnp, FNP
Family — Payments: $5,583
Family $5,583
Leah Zambouros, Np-C, NP-C
Family — Payments: $5,516
Family $5,516
Rebecca Lockwood, Arnp, ARNP
Family — Payments: $5,073
Family $5,073
Donna Gibson, Msned, Rn, Fnp-C, MSNED, RN, FNP-C
Family — Payments: $3,484
Family $3,484
Mrs. Nicole Clinchard, Fnp, FNP
Family — Payments: $2,247
Family $2,247
Jennifer Lepkowski, Fnp-C, FNP-C
Family — Payments: $2,116
Family $2,116